Avadel Pharmaceuticals-adr (AVDL) Technical Analysis
$9.40▲0.05%
Market is closed - opens 7 PM, 12 May 2025
Insights
- Avadel Pharmaceuticals-adr is currently in a favorable trading position ( BUY ) according to technical analysis indicators.
- Based on analysis of the Oscillators technical indicator, the current market trend for Avadel Pharmaceuticals-adr stock suggests that it is range bound and no decision can be made based on this information
- Based on analysis of the Moving Averages technical indicator, Avadel Pharmaceuticals-adr stock is in a uptrend ↗️
- Based on analysis of the Pivot Points, the current market trend for Avadel Pharmaceuticals-adr stock suggests that it is a good time to buy
Analysis Summary
Oscillators
Sell
Neutral
Buy
Moving Averages
Sell
Neutral
Buy
Pivots
Sell
Neutral
Buy
Oscillators
Name | Value | Action |
|---|---|---|
Relative Strength Index | 64.76 | Sell |
Stochastic | 72.27, 73.94 | Neutral |
Ultimate Oscillator | 43.87 | Neutral |
Stochastic Relative Strength Index | 91.15, 78.89 | Neutral |
Moving Average Convergence Divergence | 0.37, 0.26 | Buy |
Moving Averages
Simple Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 8.95 | Buy |
20 | 8.55 | Buy |
50 | 8.14 | Sell |
Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 8.98 | Buy |
20 | 8.65 | Buy |
50 | 8.39 | Sell |
Volume Weighted Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.1 | Neutral |
20 | 8.71 | Buy |
50 | 8.13 | Buy |
Double Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.36 | Buy |
20 | 9.1 | Buy |
50 | 8.37 | Buy |
Triple Exponential Moving Average
Period (Days) | Value | Action |
|---|---|---|
10 | 9.43 | Buy |
20 | 9.39 | Buy |
50 | 8.76 | Buy |
Pivot
Pivot | Value |
|---|---|
Resistance L3 | 10.56 |
Resistance L2 | 10.17 |
Resistance L1 | 9.78 |
Pivot Point | 9.38 |
Support L1 | 8.99 |
Support L2 | 8.6 |
Support L3 | 8.21 |
*Disclaimer: The content present here is for informational purposes only, you should not construe any such information or other material as investment advisory.